hims & hers fda warning letter compounded semaglutide 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Semaglutide Patient Safety Updates |

Compounded GLP-1 medications occupy a different regulatory category than FDA-approved brand-name drugs, and individual results vary depending on adherence, dosage, diet, activity, and individual physiology

In the United States, the 988 Suicide & Crisis Lifeline is available 24/7 by call or text

Side effects are significant for some people

Retatrutide is a novel weight management and diabetes treatment option

Both require the same volume to achieve your target concentration

If survodutide reaches market before retatrutide, it could provide early real-world evidence on glucagon receptor safety, which would benefit the retatrutide review process